Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    "22q11.2 deletion syndrome"
Show Display Options
Rank Status Study
21 Enrolling by invitation Prenatal Examination of Deletion 22q11 Syndrome : Thymic Dysgenesis THYMI Study
Condition: 22q11 Deletion Syndrome Di George Syndrome
Intervention:
22 Active, not recruiting Thymus Transplantation With Immunosuppression
Conditions: DiGeorge Syndrome;   DiGeorge Anomaly;   Complete DiGeorge Anomaly;   Complete DiGeorge Syndrome
Intervention: Biological: Thymus Tissue for Transplantation
23 Active, not recruiting Phase I/II Thymus Transplantation With Immunosuppression #950
Conditions: DiGeorge Anomaly;   Complete DiGeorge Anomaly;   Complete Atypical DiGeorge Anomaly;   Complete DiGeorge Syndrome;   Complete Atypical DiGeorge Syndrome
Interventions: Biological: Thymus Tissue for Transplantation;   Other: Thymus Tissue and Parental Parathyroid Transplantation;   Procedure: Blood Draw;   Drug: Rabbit anti-thymocyte globulin;   Drug: Cyclosporine;   Drug: Tacrolimus;   Drug: Methylprednisolone or Prednisolone;   Drug: Daclizumab;   Drug: Mycophenolate mofetil
24 Active, not recruiting Perception of Facial Emotions in Schizophrenia and 22q11 Deletion Syndrome
Condition: Schizophrenia
Interventions: Other: schizophrenia;   Other: the 22q11 deletion syndrome;   Other: control group
25 Completed Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes
Conditions: Williams Syndrome;   Angelman Syndrome;   Prader-Willi Syndrome;   Shprintzen Syndrome;   Smith-Magenis Syndrome;   DiGeorge Syndrome;   Chromosome Abnormalities
Intervention:
26 Recruiting SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
Conditions: 22q11 Deletion Syndrome;   DiGeorge Syndrome;   Trisomy 21;   Trisomy 18;   Trisomy 13;   Monosomy X;   Sex Chromosome Abnormalities;   Cri-du-Chat Syndrome;   Angelman Syndrome;   Prader-Willi Syndrome;   1p36 Deletion Syndrome
Intervention:
27 Recruiting Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
Conditions: Down Syndrome;   Edwards Syndrome;   Patau Syndrome;   Klinefelter Syndrome;   Turner Syndrome;   DiGeorge Syndrome;   Chromosome Deletion;   Aneuploidy
Intervention: Other: Blood sampling for Laboratory Developed Test (LDT) analysis
28 Recruiting Whole Blood Specimen Collection From Pregnant Subjects
Conditions: Down Syndrome;   Edwards Syndrome;   Patau Syndrome;   Klinefelter Syndrome;   Turner Syndrome;   DiGeorge Syndrome;   Perinatal Infections
Intervention: Other: Observational - no intervention
29 Recruiting Immune Disorder HSCT Protocol
Conditions: Immune Deficiency Disorders;   Severe Combined Immunodeficiency;   Chronic Granulomatous Disease;   X-linked Agammaglobulinemia;   Wiskott-Aldrich Syndrome;   Hyper-IgM;   DiGeorge Syndrome;   Chediak-Higashi Syndrome;   Common Variable Immune Deficiency;   Immune Dysregulatory Disorders;   Hemophagocytic Lymphohistiocytosis;   IPEX;   Autoimmune Lymphoproliferative Syndrome;   X-linked Lymphoproliferative Syndrome
Intervention: Drug: Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
30 Completed Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults With Repaired or Palliated Conotruncal Cardiac Defects
Conditions: Hypoparathyroidism;   Tetralogy of Fallot;   Pulmonary Valve Stenosis;   Conotruncal Cardiac Defects;   Heart Defects, Congenital;   Pulmonary Atresia
Interventions: Drug: calcium gluconate;   Drug: sodium citrate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-30) Next Page   
Study has passed its completion date and status has not been verified in more than two years.